• 제목/요약/키워드: Ischemic disease

검색결과 546건 처리시간 0.023초

허혈성 심질환(Ischemic heart disease) 환자(患者)의 사상(四象) 처방(處方) 투여 1례(例)에 대한 임상보고(臨床報告) (A Case Study of one Patient who has a ischemic heart disease(IHD))

  • 김혜원;송정모;김정호
    • 사상체질의학회지
    • /
    • 제14권2호
    • /
    • pp.125-131
    • /
    • 2002
  • An ischemic heart disease(IHD) is a anemic state of heart caused by disproportion between heart's demand and supply of oxygen. A patient who has this IHD feels serious chest pain called angina pectoris. In a keen condition it leads to a necrosis of heart muscles, known as myocardial infarction. In an ischemic heart disease the ECG waves gives us useful information of patients' heart. And CK(creatine kinase) in serum and Troponin T are the principal factors in diagnosis of IHD. In this study, the IHD patient classified by Sasang Constitutional Medicine had a notable medical effects. The symptoms of patient are disappeared and waves of ECG is closed to normal. The result of CK in serum is also recovered. So we report the healing process and results of this patient in this study.

  • PDF

우리나라 성인의 허혈성 심장질환, 뇌졸중으로 인한 총 진료비 중 과체중 및 비만의 기여분 (Medical Expenditure Attributable to Overweight and Obesity in Adults with Ischemic Heart Disease and Stroke in Korea)

  • 강재헌;정백근;조영규;송혜령;김경아
    • 보건교육건강증진학회지
    • /
    • 제27권4호
    • /
    • pp.83-90
    • /
    • 2010
  • objectives: This study was conducted to estimate medical expenditure attributable to overweight and obesity in adults with ischemic heart disease and stroke using Korea National Health and Nutrition Examination survey data and Korea National Health Corporation data. methods : The medical expenditure of ischemic heart disease and stroke related to overweight and obesity were composed of inpatient care costs, outpatient care costs and medication costs. The population attributable risk (PAR) of overweight and obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation cohort data and 2005 Korea National Health and Nutrition Examination survey data. results: The medical expenditure attributable to overweight and obesity of ischemic heart disease were 97.4 billion won(74.1-122 billion won). and stroke were 64.6 billion won(33.1-98.1 billion won). Consequently, these costs corresponded to 11.4% of total medical expenditure due to ischemic heart disease and stroke. conclusion: We conclude that overweight and obesity have increased medical expenditure from ischemic heart disease and stroke in Korea. These findings provide important support for implementing overweight and obesity management strategies in Korea.

관상동맥조영술을 받은 허혈성 심장질환자의 금연 행위에 영향을 미치는 요인 (Factors Influencing Smoking Cessation Behavior in Patients with Ischemic Heart Disease Following Coronary Angiography)

  • 김민주;문예진
    • Journal of Korean Biological Nursing Science
    • /
    • 제23권4호
    • /
    • pp.308-317
    • /
    • 2021
  • Purpose: The purpose of this study was to elucidate the relationship between readiness to quit smoking and smoking cessation, and identify factors associated with smoking cessation in smokers with ischemic heart disease post-coronary angiography (CAG). Methods: This descriptive study was conducted between December 1, 2020 and May 14, 2021 at a P hospital, Busan. A total of 164 subjects completed the questionnaire including general characteristics, coronary artery disease characteristics, readiness to quit smoking, and smoking cession behavior during hospitalization and 4 weeks after discharge. Results: The success rate of smoking cessation after coronary angiography in patients with ischemic heart disease was 49.4% (n = 81). In addition, 48.2% of smokers (n = 83) attempted smoking cessation after CAG, while 39.8% showed changes in smoking behavior. The readiness to quit smoking was significantly associated with smoking cessation (OR= 2.23, p< .005). Conclusion: Readiness to quit smoking was identified as an important factor associated with smoking cessation in patients with cardiovascular disease in this study. In order to increase the smoking cessation rate, it is necessary to strengthen the readiness to quit smoking, followed by a tailored program for smoking cessation in patients with ischemic heart disease.

의료정보를 활용한 허혈성 심장질환의 재원일수에 영향을 미치는 요인 분석 (Factors Influencing the Length of Stay Ischemic Heart Disease Utilizing Medical Information)

  • 박지경
    • 한국산학기술학회논문지
    • /
    • 제18권10호
    • /
    • pp.354-362
    • /
    • 2017
  • 인구 고령화와 서구화된 생활로 인한 허혈성 심장질환이 지속적으로 증가하고 있으며, 우리나라는 OCED 국가 중에서 허혈성 심장질환의 재원일수가 높은 국가에 속한다. 재원일수 증가는 진료비 상승의 주요 원인이므로, 허혈성 심장질환의 재원일수 관리방안 마련이 필요하다. 이에 본 연구는 허혈성 심장질환자의 재원일수에 영향을 미치는 요인을 파악하여 재원 일수 관리에 필요한 기초자료를 제공하고자 시도되었다. 연구대상자는 일개 상급종합병원의 2015년1월1일부터 12월31일까지 순환기내과의 퇴원환자 중에서 주진단명이 허혈성 심장질환인 환자 566명이다. 자료분석은 IBM SPSS ver. 23.0을 이용하여 빈도분석, 교착분석, Fisher's test, One-way ANOVA, $Scheff{\acute{e}}$ test, 더미변수를 이용한 다중회귀분석을 실시하였다. 연구결과는 첫째, 흉통을 주호소로 입원한 환자가 가장 많았다. 둘째, 평균 재원일수는 4.89일이었으며, 허혈성 심장질환 종류별로 재원일수에 차이가 있었다. 셋째, 75세이상, 당뇨병, 호흡곤란 증상이 재원일수를 증가시키는 요인으로 나타났다. 따라서 허혈성 심장질환의 적정 재원일수 관리를 위해서는 당뇨병을 동반한 허혈성 심장질환자의 경우에는 혈당조절을 통해서 질병의 진행을 막는 것이 중요하며, 증상이 나타났을 경우 빠른 시간 내에 의료기관을 방문할 수 있는 체계마련이 필요하다.

Trends in Ischemic Heart Disease Mortality in Korea, 1985-2009: An Age-period-cohort Analysis

  • Lee, Hye-Ah;Park, Hye-Sook
    • Journal of Preventive Medicine and Public Health
    • /
    • 제45권5호
    • /
    • pp.323-328
    • /
    • 2012
  • Objectives: Economic growth and development of medical technology help to improve the average life expectancy, but the western diet and rapid conversions to poor lifestyles lead an increasing risk of major chronic diseases. Coronary heart disease mortality in Korea has been on the increase, while showing a steady decline in the other industrialized countries. An age-period-cohort analysis can help understand the trends in mortality and predict the near future. Methods: We analyzed the time trends of ischemic heart disease mortality, which is on the increase, from 1985 to 2009 using an age-period-cohort model to characterize the effects of ischemic heart disease on changes in the mortality rate over time. Results: All three effects on total ischemic heart disease mortality were statistically significant. Regarding the period effect, the mortality rate was decreased slightly in 2000 to 2004, after it had continuously increased since the late 1980s that trend was similar in both sexes. The expected age effect was noticeable, starting from the mid-60's. In addition, the age effect in women was more remarkable than that in men. Women born from the early 1900s to 1925 observed an increase in ischemic heart mortality. That cohort effect showed significance only in women. Conclusions: The future cohort effect might have a lasting impact on the risk of ischemic heart disease in women with the increasing elderly population, and a national prevention policy is need to establish management of high risk by considering the age-period-cohort effect.

The Comparison of Risk Factors for Ischemic Stroke or Intracranial Hemorrhage in Korean Stroke Patients: A Nationwide Population-based Study

  • Choi, Sun-Young;Kim, Ji-In;Hwang, Shin-Woo
    • 대한의생명과학회지
    • /
    • 제24권4호
    • /
    • pp.405-410
    • /
    • 2018
  • Stroke is a leading cause of death in the Korean population and remains a major health burden worldwide. The two main pathologic types of stroke are ischemic stroke and intracranial hemorrhage (ICH), but comparisons of risk factors for these have been limited. We under took a nationwide population-based study to analyze the relationship between these risk factor sand ischemic stroke and ICH. From January 2003 to December 2013, a total of 37,561 patients with newly diagnosed ischemic stroke or ICH were identified using the National Health Insurance Service data base as the study population. Multivariable logistic regression analysis was used to determine the association between baseline risk factors and presentation with ICH versus ischemic stroke. The incidence of ischemic stroke showed an increasing rend every year, while there was no significant change in the incidence of ICH. Of the several risk factors associated with stroke, old age (OR 2.35, 95% CI 2.12~2.49, P < 0.001) was more closely associated with ischemic stroke than ICH, whereas renal disease (OR 0.74, 95% CI 0.55~0.99, P = 0.04) and carotid disease (OR 0.25, 95% CI 0.17~0.35, P < 0.001) were more strongly associated with ICH. In addition, diabetes mellitus, dyslipidemia, hypertension, ischemic heart disease and male sex was associated with an increased risk of ischemic stroke. Old age was more strongly associated with ischemic stroke than ICH, while carotid stenosis and renal impairment were more closely associated with ICH risk. Classic risk factors for stroke have considerably different associations with the two main pathologic types of stroke.

허혈성 대장염에 동반된 용혈성 요독 증후군 1례 (A Case of Hemolytic Uremic Syndrome in a Child with Ischemic Colitis)

  • 김양현;안선영;박지민;이재승
    • Childhood Kidney Diseases
    • /
    • 제8권1호
    • /
    • pp.86-90
    • /
    • 2004
  • 저자들은 복통과 구토, 혈변을 주소로 내원한 환아의 바륨 대장 조영술에서 무지문양(thumb-printing)을 확인하여 허혈성 대장염 진단하에 치료 중 미세혈관성 용혈성 빈혈과 혈소판 감소, 전해질 불균형과 급격한 소변량 감소의 급성 신부전 소견을 확인하고 허혈성 대장염에 동반된 용혈성 요독 증후군을 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

중간엽줄기세포(MSC)를 이용한 허혈성 혈관질환 치료를 위한 세포치료제 개발: 기초연구에서 임상연구 (Development of Cell Therapeutics against Ischemic Vascular Diseases Using Mesenchymal Stem Cells: From Bench to Bed)

  • 이은지;박신후;서정호;안효경;남시현;권상모
    • 생명과학회지
    • /
    • 제32권7호
    • /
    • pp.567-577
    • /
    • 2022
  • 최근 인구 고령화로 인해 허혈성 심장질환, 허혈성 뇌졸중, 말초 동맥 질환 등의 허혈성 혈관질환의 유병률이 지속적으로 증가하고 있다. 허혈성 질환에 대한 현재 표준화된 치료법은 약물 요법 및 수술을 통한 재관류요법이다. 재관류요법은 손상된 동맥의 기능을 회복시킬 수 있지만 허혈로 인해 손상된 주변 조직의 기능 회복에 있어 효율적이지 않다. 그러므로 허혈 질병을 안전하고 효과적으로 치료하고 주변 조직의 기능을 회복시킬 수 있는 새로운 치료전략의 개발이 필요하다. 이러한 한계를 극복하기 위해 손상된 부위를 재생하는 줄기세포 기반 치료가 허혈성 혈관질환의 유망한 전략으로 연구되어 왔다. 다양한 조직에서 분리할 수 있는 중간엽줄기세포(MSC)는 면역 조절, 혈관 신생 촉진 및 다양한 관련 인자의 분비를 통해 손상된 조직을 재생함으로써 허혈성 질환의 치료에 유망한 것으로 나타났다. 또한, 줄기세포 치료 효과를 높이기 위해 3D 배양법을 이용하거나 세포 프라이밍(Cell Priming)과 같은 MSC 기능을 강화하여 이식 효율을 높이는 새로운 접근법이 연구되고 있다. 이 논문에서는 MSC를 허혈성 질환 치료에 사용하는 다양한 전략을 제공하고 허혈성 부위에서 MSC의 분화(Differentiation), 증식(Proliferation) 및 생착(Engraftment)과 같은 이식의 문제에 대해 논의한다.

Atypical Extraventricular Neurocytoma

  • Choi, Hyun-Ho;Park, Sung-Hye;Kim, Dong-Gyu;Paek, Sun-Ha
    • Journal of Korean Neurosurgical Society
    • /
    • 제50권4호
    • /
    • pp.381-384
    • /
    • 2011
  • The authors report a case of atypical extraventricular neurocytoma (EVN) transformed from EVN which had been initially diagnosed as an oligodendroglioma 15 years ago. An 8-year-old boy underwent a surgical resection for a right frontal mass which was initially diagnosed as oligodendroglioma. When the tumor recurred 15 years later, a secondary operation was performed, followed by salvage gamma knife treatment. The recurrent tumor was diagnosed as an atypical EVN. The initial specimen was reviewed and immunohistochemistry revealed a strong positivity for synaptophysin. The diagnosis of the initial tumor was revised as an EVN. The patient maintained a stable disease state for 15 years after the first operation, and was followed up for one year without any complications or disease progression after the second operation. We diagnosed an atypical extraventricular neurocytoma transformed from EVN which had been initially diagnosed as an oligodendroglioma 15 years earlier. We emphasize that EVN should be included in the differential diagnosis of oligodendroglioma.

한약 투여가 허혈성 질환 환자의 혈액 응고계에 미치는 영향 (Herbal Medicines Effect on Coagulation System of Ischemic Patients)

  • 이성근;유현희
    • 동의생리병리학회지
    • /
    • 제18권4호
    • /
    • pp.1213-1217
    • /
    • 2004
  • Many ischemic disease patients have been taking herbal medicine and there are some papers that prescription of herbal medicine to ischemic disease patients are useful. Mechanism of herbal medicines on ischmeic disease have been investigated in many ways, but anticougulation or anti platelet effect of herbal medicines is not known obviously. And recently patients receiving anticougulation therapy are discouraged from taking herbal medicines. In this study, we investigate PT, INR, platelet of patients receiving herbal medicine therapy to study whether herbal medicines effect coagulation system of ischemic patients. In PT, INR, platelet values obtained from the patients, before and after administering herbal medicine, there were no significant changes.